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Abstract
Identifying and understanding the impact of gene regulatory variation is of considerable importance in evolutionary and
medical genetics; such variants are thought to be responsible for human-specific adaptation [1] and to have an important
role in genetic disease. Regulatory variation in cis is readily detected in individuals showing uneven expression of a
transcript from its two allelic copies, an observation referred to as allelic imbalance (AI). Identifying individuals exhibiting AI
allows mapping of regulatory DNA regions and the potential to identify the underlying causal genetic variant(s). However,
existing mapping methods require knowledge of the haplotypes, which make them sensitive to phasing errors. In this study,
we introduce a genotype-based mapping test that does not require haplotype-phase inference to locate regulatory regions.
The test relies on partitioning genotypes of individuals exhibiting AI and those not expressing AI in a 263 contingency
table. The performance of this test to detect linkage disequilibrium (LD) between a potential regulatory site and a SNP
located in this region was examined by analyzing the simulated and the empirical AI datasets. In simulation experiments,
the genotype-based test outperforms the haplotype-based tests with the increasing distance separating the regulatory
region from its regulated transcript. The genotype-based test performed equally well with the experimental AI datasets,
either from genome–wide cDNA hybridization arrays or from RNA sequencing. By avoiding the need of haplotype inference,
the genotype-based test will suit AI analyses in population samples of unknown haplotype structure and will additionally
facilitate the identification of cis-regulatory variants that are located far away from the regulated transcript.
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Introduction
Genetic mechanisms that modulate gene expression contribute
to human phenotypic variation and disease susceptibility [2].
Identifying regulatory elements that control RNA transcription
efficiency or level is therefore of major general and medical
interest [3]. Numerous investigations have contributed to the
identification of putative regulatory variants [4,5]. When these
variants are located on the same chromosome as the transcript
they regulate, they are expected to lead to allele-specific differences
in the expression level of cognate transcripts. The resulting allele-
specific expression (ASE) can be identified in heterozygous
individuals that differentially express the two parental copies of
the regulated transcript, also referred to as allelic imbalance (AI).
Multiple efforts have been made to detect genes exhibiting ASE
[6–9]. Less attention has been given to the mapping of regulatory
elements and finding the underlying AI-causing regulatory
variants [6,7]. Working on small genetic distances facilitated the
application of haplotype-based tests, especially when using cell
lines of the HapMap project [10,11] where chromosomal phasing,
based on family trios is relatively reliable. However, phase
uncertainty will be greater in populations of less well characterized
haplotype structure, thus reducing the power of haplotype-based
tests. Also, phasing accuracy decreases with an increasing genetic
distance, hence the detection rate of regulatory variants that are
located far away from their regulated transcripts can be
particularly affected [5,12–14]. In order to improve the mapping
efficiency of regulatory elements and variants using AI data, we
propose a genotype-based contingency test that is insensitive to
phasing errors and can be applied genome-wide to map cis-
regulatory variants. We compared this test with a standard linear
regression test used by Ge et al. [6]and with another haplotype-
based binomial test introduced here. We studied the performance
of these tests in mapping regulatory elements in genes known to
exhibit AI and where AI expressing individuals were already
ascertained. Toward this end we used computer simulated data as
well as empirical datasets of Ge et al. [6], and Montgomery et al.
[7].
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Modeling linkage disequilibrium between regulatory
elements and genes with allele-specific expression
Consider a regulatory site R that affects expression of a gene X
(Figure 1A). Of its two alleles R (ancestral) and r (derived), one
causes up-regulation and the other down-regulation of the
regulated transcript. As a consequence, RNAs transcribed from
two parental copies of this gene are unequally expressed in Rr
heterozygotes, causing AI that can be revealed by measuring
relative levels of the corresponding allelic transcripts. On the
chromosome expressing gene X, there are SNPs (referred to as
sites A) that can be tested for association with AI caused by the R
site. In Figure 1A, some of these sites (SNP1 and SNP2) are found
within the regulatory region, in the vicinity and in linkage with the
R site. Polymorphic sites that are found within the transcript itself
are used as informative markers, which allow distinguishing
between allelic transcripts from the two copies of the chromosome
and their expression levels. In this example, there is no linkage
between the regulatory region and the transcribed region
polymorphisms. Informative markers instrumental in revealing
AI and those that are informative in locating the R site are
physically separated. This emphasizes the difference between the
AI detection and the mapping of the corresponding regulatory
region. In practice the majority of cis-regulatory elements are very
close to the transcript they control, and tightly linked to the
informative markers.
When site R and any of the tested SNPs (A sites) are unlinked,
their respective alleles will segregate randomly. In contrast, SNPs
located in the vicinity of the R site, in the absence of
recombination, i.e. at complete LD between these two sites, co-
segregate in a characteristic fashion. With two bi-allelic sites, there
are four possible mutation histories, each one leading to a
characteristic haplotype trio, i.e. to a combination of three possible
haplotypes depending on the tree genealogy (Figure 2). The sites
are referred to be in ‘‘parallel’’ position when a and r mutations
originate on different branches; then both derived alleles, a and r,
will occur on different haplotypes. The A site mutation and the R
site mutation sequentially occurred on the same branch of the
genealogy, with A site mutating first (thus referred to as ‘‘above’’)
or second (‘‘below’’). Mutation histories are mutually exclusive, yet
histories 2 and 3, when the sites are in parallel position, are
indistinguishable at the level of haplotype trios (Figure 2). From
each haplotype trio, six different sets of diploid genotypes involving
two bi-allelic sites, A and R, can potentially arise (Figure 3). In each
set we find two genotypes representing Rr individuals that express
AI phenotype. Importantly, in each of these sets the distribution of
the A site genotypes differ between AI expressing individuals (Rr)
and non-AI individuals (RR and rr).
Haplotype-based tests
Observing the AI phenotype reveals the heterozygous status of
the R site. R and r alleles are associated with either up- or down-
regulation of transcription. Provided that haplotype phase is
known, two different alleles of any heterozygous SNP from the
same chromosome can be assigned to its up- or down regulated
copy (Figure 1A). In the absence of LD between the R site and
the genotyped SNPs, their A and a alleles are expected to be
distributed with equal probability between up- and down
regulated chromosomes in all AI individuals. In contrast, when
an analyzed SNP is linked to the R site, its A or a allele will tend
to be exclusively associated with only down- or up-regulated
chromosomes. The significance of LD between the R site and a
given SNP can be evaluated as binomial probability p of
observing the data, assuming equal probability of the occurrence
of each of the alleles on up- and down regulated chromosomes
(Figure 1B). Obviously, this test only makes use of AI-(Rr)
individuals that, in the same time, are Aa heterozygotes.
The second haplotype-based test is a linear regression test used
by Ge at al. [6]. It consists of fitting a linear model through the
observed individual AI intensities ordered by the genotype state of
the analyzed SNP. AI intensity is measured as a difference
between transcription levels from two parental copies, chromo-
some 1 and 2, arbitrarily numbered as they appear in the
database. The genotype state represents the allelic status of these
copies, such that ‘‘Aa’’ means ‘A’ on chromosome 2 and ‘a’ on
chromosome 1, which is different than ‘‘aA’’. Measures of
transcription levels can vary substantially from one experiment
to the other, which can directly alter linear regression significance.
Using a simple rule explained in the Methods section, we first
analyse ASE results to identify AI individuals and non-AI
individuals. Then, by definition, the AI intensity of AI expressing
individuals is either +1o r21, and zero in non-AI individuals
(Figure 1B). It usually leads to higher log(1/p) and to lower FPR of
linear regression test as compared to how it is used in Ge et al. [6]
where AI intensities are those measured directly and may differ
among individuals.
Genotype-based test
As shown in Figure 3, when R and A sites are in LD, each
haplotype trio leads to a specific set of diploid genotypes where
only one type of A-site homozygote, AA or aa, is expected to be
observed in AI individuals (Rr). In contrast, in linkage equilibrium
between different SNPs and the R site, homozygotes AA and aa as
well as heterozygotes Aa are expected to be distributed with equal
probability between AI and non-AI individuals. Therefore,
deviation from random distribution of these genotypes using
263 contingency table (Fisher’s exact–test) will indicate LD
between this A-site and the R site (Figure 1B). In the setting of
genetic association studies of complex phenotypes, this test is
usually referred to as the two degrees-of-freedom genotypic test,
and is already implemented in genetic statistical software such as
PLINK [15].
Performance of mapping tests in simulation experiments
The mapping potential of the proposed tests was studied
through simulation experiments. We simulated DNA segments
considering a range of allele frequencies at the alleged regulatory
sites in a population of constant size with and without
recombination. Recombination events were either distributed
evenly or were concentrated in recombination hotspots. For
simplicity, we only report the results considering SNPs with minor
allele frequency (MAF) of 5% or more, which mimic empirical
results using HapMap genotypes [10,11]. Table 1 presents the
simulation results of power estimates and false positive rates (FPR)
of the three tests. Because FPR is highest in the absence of
recombination, it is only reported for simulation experiments
under this condition. In the three tests considered (Figure 1B) both
power and FPR show overall dependence upon the frequency of
the r-allele and the R site heterozygosity (Table 1). In the case of
haplotype-based tests, power is positively correlated with R
heterozygosity (i.e. number of AI individuals), which is maximal
at the r-allele frequency of 0.5. In the case of the contingency test,
the highest power is observed at the r-allele frequency of 0.85, thus
correlating with the age of the regulatory mutation reflected in the
frequency of the derived allele. However, in contrast to the
contingency test, the power of haplotype-based tests is reduced due
to phasing errors. This effect is non-negligible: after rephasing
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SNPs in simulation experiments reported in Table 1. There are
additional issues to be considered when evaluating the perfor-
mance of these tests. The first concerns the spectra of possible p-
values associated with each of these tests, how these reflect the
extent of LD of the corresponding SNPs with the R site and, in the
case of haplotype based tests, how these are affected by
chromosome phasing as a function of genetic distance between
the regulatory and the transcribed sequence. The second concerns
the distribution of significant SNPs around the R site, how close
they occur and the proportion of significant SNPs of poor
‘‘mapping value’’.
To address these issues we examined the effect of chromo-
somal phasing in a situation when the regulated transcript is
located at a certain distance from its R site, separated by a
recombination hotspot placed in the middle of 100 kb as
illustrated in Figure 4. We selected simulations assigning a
regulatory site at a given r allele frequency at the beginning of
the sequence. The R and r chromosomes of each AI individual
were flagged with help of a heterozygous SNP Aa at the other
end within the transcribed portion of the sequence (Figure 4).
After rephasing, the A and a alleles were used to define R and r
chromosomes and the p values of the SNPs surrounding the
original R site were assessed again. The presence of a single
hotspot (here defining a genetic distance of ,0.1 cM) between
the virtual start site of transcription and the regulatory region
was sufficient to cause a dramatic loss of power of the haplotype-
based tests. Overall, for simulations at r frequency of ,0.35,
there is a loss of 98.7% (binomial) and 91.1% (linear regression)
of significant SNPs (at p,0.01 level) after chromosome phasing
using fastPhase [16] and 29.7% and 19.7%, respectively when
using PHASE [17] (compare Figure 4B with C, and E with F).
Therefore, from now on we will only present results obtained
with better performing PHASE software. These results are shown
Figure 1. Ideograms of linear regression and binomial haplotype-based tests, and of contingency genotype-based test. How AI
results are used in the three tests with hypothetical SNPs, SNP1 and SNP2, chosen such that SNP1 is not linked to the R-site whereas SNP2 is.
doi:10.1371/journal.pone.0038667.g001
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as a function of their corresponding r
2 coefficients with the R site.
The upper panels illustrate how the three tests perform when
phase is exactly known, and how their log(1/p) values relate to
the LD coefficient r
2. After rephasing, there is a substantial
decrease of log(1/p) values in haplotype-based tests but not in the
contingency test (see also Figures S1, S2, S3 for the data at other
frequencies of r). Furthermore, we evaluated the performance of
the tests by comparing the log(1/p) values when the extent of
phasing errors was known. After rephasing, we extracted the data
sets where all AI individuals were in phase, i.e. without phase
switch error between the regulatory and the transcribed region.
We also separated simulations where switch errors were observed
in only one individual, in two individuals and in three or more
individuals. In simulation experiments at r frequency of ,0.35,
the phase was conserved in all AI individuals (n=23) in 15.5% of
simulations, in 24% of the simulations we found switch error one
individual, in 25% in two individuals and in three or more in the
remaining 35% of simulations (Table 2). Figure 6 compares
log(1/p) values obtained in these four data sets before and after
rephasing using the contingency (red dots) and the linear
regression test (black dots). Due to phasing errors the drop in
log(1/p) values is only observed in the case of linear regression
test. While already noticeable in the data sets without switch
errors in AI individuals, the effect becomes dramatic when two
or more individuals are affected (see also Figures S4, S5, S6). It
can thus be expected that, with an increasing genetic distance
between regulated and regulatory regions, the haplotype-based
tests will become even more vulnerable. In other words, an
accumulation of phasing errors may preclude the efficient use of
haplotype based-tests in mapping regulatory regions that are
located far from their regulated transcripts [3,5,18]
If phase is exactly known the linear regression test attains the
highest log(1/p) values (.28 versus 14.08 and 9.93 for the
contingency and binomial test, respectively). On the other hand,
the average log(1/p) of about 3, considering all SNPs with p,10
22
threshold, is very similar in the three tests (Table S1). Because the
spread of the log(1/p) values is test dependent, the same numerical
value will have different weight in different tests. We also observe
that p value is not always correlated with the proximity to the R
site. In Figure 4E and 4F few ‘‘significant’’ SNPs are found
separated from the regulatory region by a recombination hotspot.
The proportion of such SNPs is not negligible and is the highest in
the case of linear regression and the lowest in the case of the
contingency test for the rephased data (Table 3). Moreover, linear
regression also appears least precise in pinpointing the location of
the R site, considering the relative position of the five most
significant SNPs (Figure S7).
Another issue is that of multiple-allelic (e.g. combination of the
effect of two or more closely related sites) or multiple-loci
regulation, whereby the same alleles of a linked polymorphic site
in different individuals can be variably associated with either up-
or down-regulation [19,20]. Potentially, this could reduce the
power of tests that require the measured effect of up- or down-
regulation to be always associated with the same parental
haplotype. For example, two independent adjacent mutations
may affect a regulatory site, such that it becomes effectively tri-
allelic. However, the third allele (formed by two-SNP haplotype)
needs to be present at an appreciable frequency. Otherwise the
two remaining alleles would dominate, making the site to behave
as effectively bi-allelic. Therefore, in our simulations we assigned
similar frequencies to the three alleles. We considered two
genealogical positions (Figure 2) with the second derived allele to
be on the background of the first (below) or to occur independently
on the background of the ancestral allele (parallel). The results
presented in Table 4 show that the three tests should also perform
well in mapping regulatory regions more complex than the bi-
allelic ones.
Figure 2. Four possible mutational pathways creating three
distinct sets of three haplotypes. Depending on the sequence of
mutations starting with the ancestral haplotype on the left, we obtain
three sets of haplotypes, referred to as below, parallel and above to
reflect the position of the A-site vs. R-site mutation on the genealogy
shown on the right. These genealogical positions can be modified by
recombination. We assume no recurrent mutations.
doi:10.1371/journal.pone.0038667.g002
Figure 3. Sets of possible genotypes under complete and
incomplete linkage disequilibrium. Under complete LD for
genealogical positions below (A), parallel (B) and above (C), there are
always two genotypes characterizing AI-individuals and only one type
of A-site homozygote present (AA or aa). Under equilibrium or
incomplete linkage disequilibrium (D) all four haplotypes involving R
and A sites are present and thus potentially all ten resulting genotypes
as well.
doi:10.1371/journal.pone.0038667.g003
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We used two different datasets obtained with cell lines
representing individuals of European descent from the CEPH
collection. The first dataset obtained using Illumina genotyping
arrays in 54 lymphoblastic cell lines by Ge et al. [6], was analyzed
in the context of HapMap2 genotypes [11]. In this study ASE was
considered as a continuous variable, representing the intensity of
the difference of normalized expression between two chromo-
somes, so called AI index. To convert AI into a categorical
variable, i.e. AI or non-AI, we considered the examined transcripts
to be in AI when their AI index was $|0.1| [6]. The second
dataset was obtained by second generation sequencing [7] of
mRNAs from 57 lymphoblastic cell lines and by matching the
sequencing results with the corresponding HapMap3 genotypes
[10]. Here the difference between the observed levels and the
expectation of equal allelic transcription at p,0.01 was used as
indicator of AI [7] (see also Methods).
Figure 7A shows the contingency test analysis of the LRRIQ3
AI data from Ge et al. [6] including SNPs from all autosomes. A
similar analysis of the TAPBP transcript based on AI data from
Montgomery et al. [7] is shown Figure 7B. It is repeated in
Figure 7C using the full sequence information of chromosome 6
obtained from the 1000 genomes project [21]. In both loci the
analysis revealed single candidate regulatory region overlapping
the examined transcript (Figures S8 and S9). Note that in
Figure 7A, the second minor peak on chromosome 15 is an
artifact caused by coincidental concentration of unlinked singleton
SNPs. As expected, the contingency test becomes especially
practical when looking for regulatory sites that are far from the
affected gene. A classic example is PTGER4 [6,14] with the
regulatory region located about 200 KB upstream of its transcrip-
tion start site. Here, the linear regression test, which performs the
best in terms of log(1/p), the binomial and the contingency test all
point to four AI-associated sites (rs7720838 at map position
40522653 bp; rs7725052 at 40523027 bp; rs9283753 at
Table 1. Power and False Positive Rate (FPR) in simulation experiments.
Power (%) FPR (%)
No Recombination Recombination No Recombination
r frequency 0.15 0.35 0.5 0.85 0.15 0.35 0.5 0.85 0.15 0.35 0.5 0.85
Test
Binomial 25 46 55 42 11 22 24 14 ,0.1 0.1 0.4 ,0.1
Contingency 27 32 31 53 16 12 9 19 0.6 0.8 0.7 ,0.1
Linear Regression 35 55 67 59 23 32 35 28 1.2 1.0 1.1 ,0.1
Note: Power was evaluated as the fraction of simulated SNPs (A sites) showing p-values,0.01 over all SNPs (only sites with MAF$5% were considered). FPR was
estimated by assigning AI status to randomly chosen individuals corresponding to the expected number of Rr heterozygotes,12, 22, 25 and 13, given r frequencies of
0.15, 0.35, 0.5 and 0.85, respectively. FPR is only reported in the case of no recombination, as it is smaller in the presence of recombination.
doi:10.1371/journal.pone.0038667.t001
Figure 4. Looking for regulatory segment ,0.1 cM from its regulated transcript. Vertical red lines in the middle correspond to the location
of the recombination hotspot, the blue line on the left indicate the location of the R site, and the horizontal black line on the upper right corresponds
to the location of the regulated transcript. Results of the binomial test with (A) known haplotypes, (B) haplotypes inferred by PHASE [17] and (C)
haplotypes inferred by fastPhase [16]; (D) results of the genotype-based contingency test, unaffected by rephasing; linear regression test using (E)
rephased data as in B and (F) rephased data as in C.
doi:10.1371/journal.pone.0038667.g004
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left in Figure 8A and 8B). The rs7720838 SNP, which was already
reported previously (Table 5) is in complete LD with the three
others. In turn, in the case of TTC39b, it is only the contingency
test that highlights a potential regulatory region at about 600 KB
downstream from the gene (Figure 9C; see also Table 5). The
failure of the binomial and linear regression test (Figure 9A and
9B) to pinpoint the same region as a regulatory candidate is
presumably related to a greater genetic distance separating it from
the regulated TTC39b transcripts than in the case of PTGER4
(600 vs. 200 Kb and even greater difference in genetic distances
when comparing r, the population recombination rate intensities
in Figures 8D and 9D). Note, however, that in the same time, both
haplotype based tests reveal a number of significant SNPs (one
highly significant, p=2.5610
27, in the case of linear regression)
among those within the transcript itself and used as informative
markers for the detection of AI.
While in many instances the contingency test outperforms the
binomial one (Figures S8, S9, S10, S11, S12, S13), they often
perform equally well (Figures S14, S15, S16) or the binomial one
appears more efficient (Figure S17). As a rule log(1/p) values are
much higher in the case of linear regression. Both experimental
datasets [6,7] provided high-quality data to reveal the presence of
ASE (Figure S18), although the significant sites did not always fully
overlap due to differences in the SNP catalogs between HapMap2
and HapMap3. Table 5 lists selected SNPs identified by us and
known previously from other studies to provide additional support
and verification of our approach. SNPs density can be easily
increased by incorporating into the analysis the sequence data of
the 1000 genomes project available for the same population
samples (Figure 7C).
Empirical False Positive Rate
In power calculations based on the empirical data we examined
all HapMap2 autosomal SNPs (.2.5 million) in the set of 54
individuals from Ge et al. [6], assuming the presence of AI in a
range of randomly chosen individuals (Table 6). These estimates
show that the overall FPR is less than 1% for all tests at these
conditions. We can therefore presume that scanning the whole
genome will rarely give rise to misleading regions of significant
SNPs. Especially considering most false positives would occur
alone, while significant SNPs are expected to occur in clusters
representing genomic segments in LD. To identify such segments
we additionally examined [22] the recombination rate and LD
profiles in the identified regions, as shown in Figures 8C and 9C.
Figure 5. Extent of linkage disequilibrium and significance level. Plots of r
2 coefficients between the R site and all tested SNPs and the
corresponding log(1/p) from simulations at r frequency of ,0.35, with known phase (upper panels) and after rephasing with PHASE [17] (lower
panels), for the binomial (A and B), linear regression (C and D) and contingency tests (E and F).
doi:10.1371/journal.pone.0038667.g005
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Variation in transcriptional regulation of gene expression plays
a significant role in determining the diversity of human
phenotypes. The components of transcriptional control include
cis-acting regulatory elements that may act across large genomic
distances, hundreds or thousands of Kb away from the transcript
they regulate [18]. Studies of ASE indicate that allele-specific
differences among transcripts within an individual can affect up
to 30% of loci and, at the population level, ,30% of expressed
genes show evidence of cis regulation by common variants [6]. In
population studies, an even larger proportion of genes showed
ASE that could not be mapped, which could be ascribed to rare
genetic variants or epigenetic effects [8]. However, it is also
possible that some distal regulatory regions have escaped
detection because they are located far from the regulated
transcript. First, because of large distance they could have been
left unexplored, and second, because the mapping could have
failed, if tests required knowledge of the chromosomal phase.
Sample size, the reliability of genotyping and the accuracy and
completeness of AI ascertainment, will affect the outcome of all
tests. Because genotype-based test is independent of chromosom-
al phasing and phasing errors, its mapping efficacy is also
unaffected by genetic distance separating regulatory site from the
Figure 6. Comparison of log(1/p) values obtained before and after rephasing with PHASE. Simulations at r frequency of ,0.35 (i.e.
around 23 AI individuals out of a total of 50) were used and results were separated according to the rephasing quality evaluated as (A) zero, (B) one,
(C) two and (D) three or more, AI individuals with phase switch error.
doi:10.1371/journal.pone.0038667.g006
Table 2. Phase switch errors in AI individuals due to
rephasing (%).
r frequency
Number of errors 0.15 0.35 0.50 0.85
0 34.6 15.5 14.6 43.5
1 33.6 24.3 20.8 27.9
2 20.3 25.4 25.0 16.0
3 or more 11.5 35.0 39.8 12.5
Phase switch errors between the direction of AI and the original haplotype
phase of R and r alleles observed after rephasing (using PHASE) the simulation
data for different r frequencies.
doi:10.1371/journal.pone.0038667.t002
Table 3. Proportion of significant SNPs separated from
regulatory region by a recombination hotspot (as in Figure 4).
r frequency
0.15 0.35 0.50 0.85
Binomial Test
Phase known 5.3 6.5 9.4 23.2
After re-phasing 9.6 9.0 12.8 32.4
Contingency Test
Phase known 12.9 5.7 7.1 23.4
After re-phasing 12.9 5.7 7.1 23.4
Linear Regression
Phase known 17.4 12.5 14.2 27.7
After re-phasing 20.8 15.2 17.2 30.9
A hotspot has been simulated between the transcript locus and the regulatory
rSNP as illustrated in Figure 4.
doi:10.1371/journal.pone.0038667.t003
Mapping Regulatory Variation
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using best haplotype-phase inference algorithms [23]. Their
number increases with increasing chromosomal distances and
with the number of recombination hotspots in between. They
may be also more frequent in admixed individuals and in newly
studied populations with unknown haplotype catalogs [24]. The
most accurate algorithms, such as PHASE require very long
computation times (on a regular 2 GHz computer), which may
extend from days to months for sets of hundreds of thousands of
SNPs in a hundred genotyped individuals [16,25]. While this was
not an issue with our simulated data sets of 50 diploid individuals
and an average of about 500 SNPs (h=100), it still took more
than 50 min on 2.67 GHZ processor. Faster programs exist and,
for example, it takes about 2 min run to phase the same data set
using ShapeIT [25]. Regrettably, the speed is reached at the
expense of accuracy which varies as a function of the sample size
and the amount of markers [26]. In other words, using genotype
test is less computationally demanding, we gain in time and in
accuracy when phasing errors are an issue.
Our analyses on real data were carried out in very well phased
CEU individuals from the HapMap project, where phasing was
additionally improved by using child-parental trios. In most cases
the haplotype-based binomial test worked equally well or even
better than the genotype-based test as judged by significance
levels. However, while both tests ‘‘found’’ the PTGER4 cis-
regulatory segment located almost 200 kb upstream of this gene
(Figure 8), our binomial and linear regression test failed to
identify such a region more than 500 kb downstream of the
TTC39b transcript (Figure 9). When we rephased the genotype
data from Figure 8 using fastPhase [16] (but not PHASE [17] or
Shape-IT [25]), the upstream regulatory segment of the
PTGER4 transcript also became ‘‘invisible’’ in the haplotype
based tests. Therefore, when chromosomes are well phased these
tests can be expected to lead to the same or similar overlapping
results (e.g. Figure 8). Importantly, these two examples (Figures 8
and 9) illustrate well the problem of locating regulatory variants/
regions from ASE data. An informative marker whose alleles are
at least partly consistent with the direction of up and down
transcription control may be revealed as significant. The chances
that this happens are increased when many such markers are
used (or when many transcripts are tested with highly informative
markers) and haplotype-based tests seem to be more vulnerable
to this kind of error. Lack of statistical significance in the
genotype-based vs. haplotype-based tests of a number of SNPs
representing the informative markers zone, as in Figure 9,
strongly suggests that these do not indicate the location of the
regulatory region but rather reflect a partial overlapping in
heterozygosity and phase between marker and regulatory sites. In
the reverse case, lack of statistical significance in the haplotype-
based vs. the genotype-based test may also suggest a different
genetic mechanism. For example, in the case of an imprinted
locus, when one of the parental chromosomes is silenced, a signal
of AI will be observed [27]. This is observed in the SNRPN locus
(Figure S19) reported to be imprinted [28], and in the L3MBTL
locus (Figure S20) where haplotype based analyses failed and the
contingency test revealed as significant the informative markers
and other SNPs in their linkage group. Likewise, an ‘‘artificial’’
AI signal could also reflect random mono-allelic expression in a
fraction of individuals (cell lines), due to aberrant methylation of
the genome [27]. In other words, combining the results of
haplotype and genotype-based tests may provide leads to AI-
causing mechanisms other than due to genetic variation within
regulatory elements. In Table 5 we listed selected SNPs found by
us, which were earlier reported in either different GWAS or
expression studies by others. For example, PTGER4 rs7720838
was found associated with the risk of Crohn’s disease [14]. The
rs1384883 SNP from LRRIQ3 was reported in a GWAS of
blood pressure and hypertension [29], while other SNPs
Table 4. Power and FPR in simulation experiments of a tri-
allelic R-site.
Power (%) FPR (%)
Position Parallel Below
Test
Binomial 58 38 0.3
Contingency 39 37 1
Linear Regression 64 47 1
Power is separately evaluated for the two possible genealogical positions
above/parallel and above/below of the derived alleles r1 and r2. The
frequencies were 0.4, 0.3 and 0.3 for the ancestral haplotype (R1R2), the
intermediate (R1r2 or r1R2) and the derived (r1r2), respectively. FPR was
calculated by randomly assigning 33 individuals as AI positive.
doi:10.1371/journal.pone.0038667.t004
Figure 7. Manhattan plots of p-values from the contingency
test. (A) for all autosomes using HapMap2 polymorphisms and AI data
for LRRIQ3; (B) using HapMap3 polymorphisms and AI data for TAPBP;
and (C) using 1000 genomes sequences for chromosome 6 and the
same AI data for TAPBP.
doi:10.1371/journal.pone.0038667.g007
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in gene expression studies [30,31]. The SNP rs751173 (transcript
404053) was reported in a study of susceptibility to cutaneous
nevi [32], these associated with AI of the transcript 404105 were
highlighted in a GWAS on late-onset Alzheimer disease, with
rs2180566 found in the promoter of DEFB123 [33]. In turn,
LTA locus with rs2844484 and rs2239704 was found in studies
of cancer susceptibility and the risk of ischemic stroke [34–36].
All the remaining sites were earlier identified in studies of gene
expression in the context of eQTL mapping. Thus our findings
here can be considered as confirmatory. Interestingly, however,
the three SNPs listed in the context of TTC39b, and found in
the larger cluster of significant sites based on the data shown in
Figure 9, were reported in the context of the PSIP1 transcript,
about 150 kb upstream from TTC39b [7]. Likewise, rs1963273
identified in the context of the FMO1 transcript [37] was found
here to be linked to AI within FMO4 (Figure S10) and SNPs
listed for BAT2 were previously reported in LD with CSNK2B
transcription [37,38]. Do these results represent examples of
synchronized transcription control, as could be suspected in the
Figure 8. Mapping regulatory sites for PTGER4. Plots of p-values for HapMap2 SNPs using binomial test (A), linear regression test (B) and
contingency test (C). Vertical black lines identify SNPs that were used as informative markers within the transcript and the green horizontal line
corresponds to the analyzed transcript. The linkage disequilibrium triangle and recombination intensity profile of the population recombination rate
(r/kb estimated by InfRec [22]) are shown in (D), where, black lines connect SNPs distributed according to sequence position (upper part) with their
position in the LD triangle and vertical green lines delimit the size of the analyzed transcript. Arrow on the top indicates transcription direction.
doi:10.1371/journal.pone.0038667.g008
Figure 9. Mapping regulatory sites for TTC39b. Plots of p-values for HapMap2 SNPs using binomial test (A), linear regression test (B) and
contingency test (C). Vertical black lines identify SNPs that were used as informative markers within the transcript and the green horizontal line
corresponds to the analyzed transcript. The linkage disequilibrium triangle and recombination intensity profile of the population recombination rate
(r/kb estimated by InfRec [22]) are shown in (D), where, black lines connect SNPs distributed according to sequence position (upper part) with their
position in the LD triangle and vertical green lines delimit the size of the analyzed transcript. Arrow on the top indicates transcription direction.
doi:10.1371/journal.pone.0038667.g009
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due to experimental artefacts partly caused by phasing errors?
In contrast to other analyses, which may consider the intensity
of the ASE signal [6], the tests introduced here are based on a
categorical classification of the individuals studied as AI or non-
AI. The mapping of regulatory variation thus critically depends
on the quality of AI measurement as well as on the number of
intergenic informative marker SNPs serving to ascertain AI status
of the sampled individuals. Detecting or confirming the presence
of AI is not the same as mapping regulatory variants. For the
first it is sufficient to demonstrate that two parental copies of a
gene are differentially expressed. Mapping requires sufficiently
large samples where ideally all AI expressing individuals can be
detected. Power and FPR of the mapping tests depend upon the
characteristics of the polymorphic sites in LD within a regulatory
segment (Table 1). These characteristics, which include their
allelic frequencies, genealogical positions and r
2 relative to the R
site, change with the increasing r frequency (Figure S21 and
Table S2). Selecting simulations for the presence of a derived
allele above certain frequency level eliminates a portion of
coalescence trees representing particular genealogical histories
that cannot ‘‘accommodate’’ sites with a derived allele above
certain frequency level. While among 2000 simulated genealogies
all ‘‘carry’’ a site with a derived allele frequency of ,0.15, only
897 (45%) genealogies carried sites with a derived allele
frequency of ,0.85 (Table S2). This leads to a progressive
distortion (as compared to neutral expectation) of allelic
frequency spectra of SNPs in LD with the R site at increasing
frequency of its r allele (Figure S22), which affects the
proportions of significant SNPs in each position category
between the tests. Knowing the number of AI individuals we
may estimate heterozygosity and thus relative R and r allele
frequencies. The knowledge of the expected genealogical
Table 5. Examples of sites identified in previous studies.
Transcript
[direction: .; ,] rSNP Sequence position Reference
PTGER4. chr 5 40715789–40729594
rs7720838 40522653 1
rs7725052 40523027
rs9283753 40526366
rs10440635 40526547
TTC39b, chr 9 15176585–15297244
rs10481503 14650700 2*
rs10481504 14650873 2*
rs9298706 14668730 2*
LRRIQ3, chr 1 74264290–74436459
rs1384883 74274065 3
rs6676622 74282393 4*
rs1032082 74304575 4*
rs11210404 74310840 4*
rs1483795 74315515 4*
rs10789387 74332999 4*
rs10789388 74341340 4*
rs4142948 74344939 4*
rs11806946 74436297 5
TAPBP, chr 6 33379710–33389967
rs469064 33358454 2*
rs455567 33360093 2*
rs446735 33363081 2*
rs463260 33364962 2*
rs464865 33365164 2*
rs3130018 33398380 2*
rs2073525 33398803 2*
rs3130267 33414772 2*
rs3130270 33416199 2*
404053. chr 9 21684732–21687392
rs751173 21697372 6
404105, chr 20 29336791–29338299
rs2180566 29482515 7
rs6059244 29474144 7
BAT2. chr 6 31696429–31713533
rs805257 31742172 8*
rs755714 31717792 8*
rs2736172 31698877 9*
rs805297 31730585 9*
FMO4. chr 1 169550110–69577847
rs1963273 169589070 9*
GUCA1b, chr 6 42259000–42270672
rs4714579 42282456 10
KIF16b, chr 20 16307450–16502078
rs3746786 16515202 10
rs2277777 16518934 5
rs6075078 16519466 5
LTA. chr 6 31648684–31649608
rs2844484 31644203 11,12
Table 6. Empirical False Positive Rate estimates.
FPR (%)
AI individuals 5 10 15 20 29
Test
Binomial 0.00 0.01 0.1 0.17 0.26
Contingency 0.60 0.66 0.69 0.72 0.72
Linear Regression 0.06 0.34 0.34 0.54 0.59
Percent of SNPs showing p-values below 0.01, after randomly assigning AI to 5,
10, 15, 20 and 29 individuals out of the 54 considered (based on the set of Ge et
al.). Based on 20 whole genome scans for 10, 15 and 20 AI individuals and on 20
scans of chromosomes 1 to 4 for 5 and 29 AI individuals.
doi:10.1371/journal.pone.0038667.t006
Table 5. Cont.
Transcript
[direction: .; ,] rSNP Sequence position Reference
rs2239704 31648120 13
MDGA1, chr 6 37708262–37773744
rs6938061 37782317 14
References for Table 5: 1. [14]; 2. [7]; 3. [29]; 4. [31]; 5. [30]; 6. [32]; 7. [33]; 8. [38];
9. [37]; 10. [6]; 11. [36]; 12. [34]; 13. [35]; 14. [45]. *: Reference found through the
eQTL browser (http://eqtl.uchicago.edu/cgi-bin/gbrowse/eqtl/).
doi:10.1371/journal.pone.0038667.t005
Mapping Regulatory Variation
PLoS ONE | www.plosone.org 10 June 2012 | Volume 7 | Issue 6 | e38667positions of SNPs that are tightly linked with the R site allows us
to better understand differences between outcomes of different
tests (Table S2). When combined with the analysis of the
regulatory region haplotypes it may be also useful in finding the
regulatory site itself.
Systematic use of genotype-based tests in concert with
haplotype-based tests may be the most advisable mapping strategy.
Unfortunately, haplotype-based tests will always suffer from
phasing uncertainty inherent to the data itself, especially when
the number of samples precludes the use of computationally slow
but more reliable phasing algorithms. Using the genotype-based
test, the phasing step can be simply postponed saving time and
related costs. The best outcomes can be expected with high quality
data maximizing ascertainment of AI individuals. The utility of the
genotype-based test will increase with the application of new
sequencing methods that improve transcript quantification thus
providing more reliable assessment of AI status. Without phasing
uncertainty, the genotype-based test should pave the road to the
identification of cis-regulatory variants that could have escaped
detection due to their distal location [4,18]. Finally, the current
trend of functional genomics based on next-generation sequencing
makes it possible to interrogate allelic functional effects beyond
transcription [8]. Any inheritable phenotypes that can be
categorized such as AI here, identifying the underlying heterozy-
gotes, can be mapped using presented protocols. The genotype test
can also be extended to compare phenotyped individuals that may
represent different genotype combinations. Our approaches can
be generalized to map for causes of differential DNA-protein
interactions or active chromatin, both shown to be inheritable in
recent studies [39,40].
Methods
Evaluation of statistical tests by simulation experiments
Coalescent simulations were performed using the programs ms
[41] and msHot [42]. A typical experiment consisted of 2000
simulations of 50 individuals (i.e., 100 sequences) with a
population mutation rate H of 50. Considering effective popula-
tion size Ne of 12 500 individuals and mutation rate m of 2610
28
per nucleotide per generation leads to the sequence of 50 Kb. In
the presence of recombination, the population recombination rate
r was set to 25. When hotspots were simulated, 90% of all
recombinations occurred within a single hotspot of 1 kb in the
middle of the sequence. Genotypes were constructed by randomly
pairing simulated haplotypes and the resulting Rr heterozygotes
were considered as AI individuals.
In each simulation, among the entire set of simulated SNPs, we
selected an rSNP with a specific frequency at its derived allelic
state, r frequency of 0.15, 0.35, 0.5 and 0.85 (or in the closest
interval) and assigned it as an R site. The remaining mutations
were considered as accompanying SNPs (A sites). In practice, our
r-alleles chosen from simulation experiments had frequencies of
0.14460.021, 0.33760.046, 0.49560.056 and 0.84760.060,
respectively. Importantly, not all of the simulations carried derived
alleles above 0.15, such that from 2000 simulations in the absence
of recombination, only 1954 remained in a sample with r-allele
frequency of 0.35, 1681 with r frequency of 0.5 and 897 with r
frequency of 0.85. The data obtained in each simulation
experiment were used to estimate power and FPR of the three
tests. To evaluate the extent of linkage disequilibrium between
rSNP and other sites we used r
2 coefficient [43].
Power was estimated as the fraction of significant sites (p,0.01)
over all sites or over all sites with MAF of 5% or more. To evaluate
FPR (type I error), we first calculated the mean number of Rr
heterozygotes corresponding to AI individuals in each experiment
and then, we randomly assigned AI status to the same number of
simulated individuals. The number of significant sites over all
SNPs, or those at MAF$5%, yields the FPR. The number of
simulations having at least one significant SNP was also computed
for the FPR.
Phasing errors and incomplete ascertainment of AI
individuals
To test the effect of phasing haplotypes from the genotypes we
compared the results obtained from the diploid individuals
created using original simulated haplotypes with the ones using
haplotypes inferred from the reconstructed genotypes by
fastPhase [16] and PHASE [17]. In addition, we carried
simulations as described above for 50 individuals, except that
there were 1000 simulations, H and r were set to 100 and 50,
respectively. Thus sequences were 100 kb long, a recombination
hotspot 1 kb wide was placed in the middle of the sequence with
90% percent of all recombinations occurring within the hotspot.
We defined AI individuals as heterozygous for the R site
preselected for desired r frequency and located at one end of the
sequence. In AI individuals, we used heterozygous SNPs at the
other end of the sequence to keep track of the phase of AI after
rephasing (see Figure 4). This way the effect of phasing errors
between a putative R site and the regulated transcript separated
by hotspots can be evaluated.
Tri-allelic R site
To estimate the performance of the tests given the tri-allelic R-
site, we used simulations under the same conditions with no
recombination involved. We combined two mutations to obtain
three haplotypes that would confer distinct levels of allelic
expression. Let us denote R1 and r1 the ancestral and derived
alleles at the first site, and R2 and r2 the corresponding alleles at
the second site. We arbitrarily assumed the lowest expression level
to be associated with the ancestral haplotype R1R2. The first
mutation that leads to the haplotypes r1R2 or R1r2 will be
associated with an intermediate expression and the second
mutation leading to the r1r2 variant was assigned to confer the
highest expression level. In this three-allelic model, we considered
frequencies of 0.4, 0.3 and 0.3 for the ancestral, intermediate and
the derived variant, respectively.
Empirical evaluation of statistical tests
To evaluate the distribution of the observed p-values, we used
the same 54 individuals with their HapMap2 genotypes that were
analyzed by Ge et al [6]. From this sample, we randomly chose 5,
10, 15, 20, 25 or 29 individuals, as if they were in AI.
Subsequently, we evaluated p-values for each SNP along the
whole genome (for 5 and 29 individuals rather than whole genome
we only used chromosomes 1, 2, 3 and 4 instead). This was
repeated 20 times for each number of randomly assigned AI
individuals.
Using the data
The data on differential ASE determined in 54 lymphoblastic
cell lines are from Ge et al. [6]. Briefly, several markers were used
along the genome to evaluate allelic expression. Markers are
considered informative when they are heterozygous and their
expression intensity is sufficiently high as in R=log(Xraw+Yraw).1000.
The AI indices measured by |D het ratio|e v a l u a t et h ed i f f e r e n c ei n
expression level between two allelic chromosomes and we set the
threshold over which it indicates differential ASE to 0.1. However, the
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reportingconsistentresults.Inpractice,thereis asubstantialvariancein
signal intensity and in AI indices between informative marker-SNPs
within a single individual [44]. Since our tests require partitioning AI
and non-AI individuals as well as possible, we carefully evaluated AI for
each individual. We used the mean AI either from all informative
markers (heterozygote markers within that individual) or considering
only significant markers (R.1000). In both cases, the individual was
considered in AI when his AI index was over 0.1.
We also used second generation sequencing results from
Montgomery et al. [7] where differential allelic expression was
examined by counting transcripts in heterozygous individuals,
using polymorphic markers from the HapMap3 project in the 113
HapMap lymphoblastic cell lines representing individuals of
European descent. The presence of differential allelic expression
was assessed based on a binomial probability of differences in raw
counts for each allele with correction for reference mapping biases.
When an individual had at least one marker with a p-value,0.01,
he was considered in AI.
The extent of genetic distance between SNPs of the analyzed
DNA regions was assessed by LD-triangles, representing the
significance of association between SNPs based on x
2 or Fisher’s
exact test, and by plotting the intensity profiles of the population
recombination rate r obtained by InfRec [22].
Supporting Information
Figure S1 Extent of linkage disequilibrium and signif-
icance level. Plots of r
2 coefficient between the R site and all
tested SNPs and the corresponding log(1/p) from simulations at r
frequency of ,0.15, with known phase (upper panels) and after
rephasing with PHASE (lower panels), for the binomial (A and B),
linear regression (C and D) and contingency test (E and F).
(TIF)
Figure S2 Extent of linkage disequilibrium and signif-
icance level. Plots of r
2 coefficient between the R site and all
tested SNPs and the corresponding log(1/p) from simulations at r
frequency of ,0.5, with known phase (upper panels) and after
rephasing with PHASE (lower panels), for the binomial (A and B),
linear regression (C and D) and contingency test (E and F).
(TIF)
Figure S3 Extent of linkage disequilibrium and signif-
icance level. Plots of r
2 coefficient between the R site and all
tested SNPs and the corresponding log(1/p) from simulations at r
frequency of ,0.85, with known phase (upper panels) and after
rephasing with PHASE (lower panels), for the binomial (A and B),
linear regression (C and D) and contingency test (E and F).
(TIF)
Figure S4 Comparison of log(1/p) values obtained
before and after rephasing with PHASE. Simulations at r
frequency of ,0.15 (i.e. around 23 AI individuals out of a total of
50) were used and results were separated according to the
rephasing quality evaluated as (A) zero, (B) one, (C) two and (D)
three or more, AI individuals with phase inversion.
(TIF)
Figure S5 Comparison of log(1/p) values obtained
before and after rephasing with PHASE. Simulations at r
frequency of ,0.5 (i.e. around 23 AI individuals out of a total of
50) were used and results were separated according to the
rephasing quality evaluated as (A) zero, (B) one, (C) two and (D)
three or more, AI individuals with phase inversion.
(TIF)
Figure S6 Comparison of log(1/p) values obtained
before and after rephasing with PHASE. Simulations at r
frequency of ,0.85 (i.e. around 23 AI individuals out of a total of
50) were used and results were separated according to the
rephasing quality evaluated as (A) zero, (B) one, (C) two and (D)
three or more, AI individuals with phase inversion.
(TIF)
Figure S7 Distributions of the mean distances of the 5
lowest p-values A-sites to the regulatory SNP. Simulation
results with recombination are shown by the red line (uniform) and
green bars (single recombination hotspot). Those in the absence of
recombination are shown by the blue line. The results from the
binomial, contingency and linear regression tests are presented in
downward order.
(TIF)
Figure S8 Mapping regulatory sites for LRRIQ3 (Ge,
Pokholok et al. 2009). Plots of p-values for HapMap2 SNPs
using binomial test (A), linear regression test (B) and contingency
test (C). Vertical black lines identify SNPs that were used as
informative markers within the transcript and the green horizontal
line corresponds to the analyzed transcript. (D)The linkage
disequilibrium triangle and recombination intensity profile of the
population recombination rate (r/kb estimated by InfRec), where,
black lines connect SNPs distributed according to sequence
position (upper part) with their position in the LD triangle and
vertical green lines delimit the size of the analyzed transcript.
Arrow on the top indicates transcription direction.
(TIF)
Figure S9 Mapping regulatory sites for TAPBP (Mon-
tgomery, Sammeth et al. 2010). Plots of p-values for
HapMap3 SNPs using binomial test (A), linear regression test (B)
and contingency test (C). Vertical black lines identify SNPs that
were used as informative markers within the transcript and the
green horizontal line corresponds to the analyzed transcript. (D)
The linkage disequilibrium triangle and recombination intensity
profile of the population recombination rate (r/kb estimated by
InfRec), where, black lines connect SNPs distributed according to
sequence position (upper part) with their position in the LD
triangle and vertical green lines delimit the size of the analyzed
transcript. Arrow on the top indicates transcription direction.
(TIF)
Figure S10 Mapping regulatory sites for FMO4 (Mon-
tgomery, Sammeth et al. 2010). Plots of p-values for
HapMap3 SNPs using binomial test (A), linear regression test (B)
and contingency test (C). Vertical black lines identify SNPs that
were used as informative markers within the transcript and the
green horizontal line corresponds to the analyzed transcript. (D)
The linkage disequilibrium triangle and recombination intensity
profile of the population recombination rate (r/kb estimated by
InfRec), where, black lines connect SNPs distributed according to
sequence position (upper part) with their position in the LD
triangle and vertical green lines delimit the size of the analyzed
transcript. Arrow on the top indicates transcription direction.
(TIF)
Figure S11 Mapping regulatory sites for LTA (Mon-
tgomery, Sammeth et al. 2010). Plots of p-values for
HapMap3 SNPs using binomial test (A), linear regression test (B)
and contingency test (C). Vertical black lines identify SNPs that
were used as informative markers within the transcript and the
green horizontal line corresponds to the analyzed transcript. (D)
The linkage disequilibrium triangle and recombination intensity
profile of the population recombination rate (r/kb estimated by
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sequence position (upper part) with their position in the LD
triangle and vertical green lines delimit the size of the analyzed
transcript. Arrow on the top indicates transcription direction.
(TIF)
Figure S12 Mapping regulatory sites for GUCA (Ge,
Pokholok et al. 2009). Plots of p-values for HapMap2 SNPs
using binomial test (A), linear regression test (B) and contingency
test (C). Vertical black lines identify SNPs that were used as
informative markers within the transcript and the green horizontal
line corresponds to the analyzed transcript. (D)The linkage
disequilibrium triangle and recombination intensity profile of the
population recombination rate (r/kb estimated by InfRec), where,
black lines connect SNPs distributed according to sequence
position (upper part) with their position in the LD triangle and
vertical green lines delimit the size of the analyzed transcript.
Arrow on the top indicates transcription direction.
(TIF)
Figure S13 Mapping regulatory sites for BAT2 (Ge,
Pokholok et al. 2009). Plots of p-values for HapMap2 SNPs
using binomial test (A), linear regression test (B) and contingency
test (C). Vertical black lines identify SNPs that were used as
informative markers within the transcript and the green horizontal
line corresponds to the analyzed transcript. (D)The linkage
disequilibrium triangle and recombination intensity profile of the
population recombination rate (r/kb estimated by InfRec), where,
black lines connect SNPs distributed according to sequence
position (upper part) with their position in the LD triangle and
vertical green lines delimit the size of the analyzed transcript.
Arrow on the top indicates transcription direction.
(TIF)
Figure S14 Mapping regulatory sites for transcript
404053 (Montgomery, Sammeth et al. 2010). Plots of p-
values for HapMap3 SNPs using binomial test (A), linear
regression test (B) and contingency test (C). Vertical black lines
identify SNPs that were used as informative markers within the
transcript and the green horizontal line corresponds to the
analyzed transcript. (D) The linkage disequilibrium triangle and
recombination intensity profile of the population recombination
rate (r/kb estimated by InfRec), where, black lines connect SNPs
distributed according to sequence position (upper part) with their
position in the LD triangle and vertical green lines delimit the size
of the analyzed transcript. Arrow on the top indicates transcription
direction.
(TIF)
Figure S15 Mapping regulatory sites for transcript
404105 (Montgomery, Sammeth et al. 2010). Plots of p-
values for HapMap3 SNPs using binomial test (A), linear
regression test (B) and contingency test (C). Vertical black lines
identify SNPs that were used as informative markers within the
transcript and the green horizontal line corresponds to the
analyzed transcript. Arrow on the top indicates transcription
direction. Two crossed sites represent SNPs that were identified in
the GWAS on late-onset Alzheimer disease: rs2180566 in the
DEFB123 (orange line) promoter and rs6059244 more to the left
(see Table 3). (D) The linkage disequilibrium triangle and
recombination intensity profile of the population recombination
rate (r/kb estimated by InfRec), where, black lines connect SNPs
distributed according to sequence position (upper part) with their
position in the LD triangle and vertical green lines delimit the size
of the analyzed transcript.
(TIF)
Figure S16 Mapping regulatory sites for MDGA1 (Ge,
Pokholok et al. 2009). Plots of p-values for HapMap2 SNPs
using binomial test (A), linear regression test (B) and contingency
test (C). Vertical black lines identify SNPs that were used as
informative markers within the transcript and the green horizontal
line corresponds to the analyzed transcript. (D)The linkage
disequilibrium triangle and recombination intensity profile of the
population recombination rate (r/kb estimated by InfRec), where,
black lines connect SNPs distributed according to sequence
position (upper part) with their position in the LD triangle and
vertical green lines delimit the size of the analyzed transcript.
Arrow on the top indicates transcription direction.
(TIF)
Figure S17 Mapping regulatory sites for KIF16b (Ge,
Pokholok et al. 2009). Plots of p-values for HapMap2 SNPs
using binomial test (A), linear regression test (B) and contingency
test (C). Vertical black lines identify SNPs that were used as
informative markers within the transcript and the green horizontal
line corresponds to the analyzed transcript. (D)The linkage
disequilibrium triangle and recombination intensity profile of the
population recombination rate (r/kb estimated by InfRec), where,
black lines connect SNPs distributed according to sequence
position (upper part) with their position in the LD triangle and
vertical green lines delimit the size of the analyzed transcript.
Arrow on the top indicates transcription direction.
(TIFF)
Figure S18 Comparison of the results from Ge, Pokho-
lok et al. 2009 (left, based on HapMap2) with those from
Montgomery, Sammeth et al. 2010 (right, based on
HapMap3). Plots of p-values for HapMap2 (left) and HapMap3
(right) SNPs using binomial test (A), linear regression test (B) and
contingency test (C). Vertical black lines identify SNPs that were
used as informative markers within the transcript and the green
horizontal line corresponds to the analyzed transcript. (D)The
linkage disequilibrium triangle and recombination intensity profile
of the population recombination rate (r/kb estimated by InfRec),
where, black lines connect SNPs distributed according to sequence
position (upper part) with their position in the LD triangle and
vertical green lines delimit the size of the analyzed transcript.
Arrow on the top indicates transcription direction.
(TIFF)
Figure S19 Analysis of ASE in SNRPN. Plots of p-values for
HapMap3 SNPs using binomial test (A), linear regression test (B)
and contingency test (C). Vertical black lines identify SNPs that
were used as informative markers within the transcript and the
green horizontal line corresponds to the analyzed transcript. (D)
The linkage disequilibrium triangle and recombination intensity
profile of the population recombination rate (r/kb estimated by
InfRec), where, black lines connect SNPs distributed according to
sequence position (upper part) with their position in the LD
triangle and vertical green lines delimit the size of the analyzed
transcript. Arrow on the top indicates transcription direction.
(TIF)
Figure S20 Analysis of ASE in L3MBTL. Plots of p-values
for HapMap2 SNPs using binomial test (A), linear regression test
(B) and contingency test (C). Vertical black lines identify SNPs that
were used as informative markers within the transcript and the
green horizontal line corresponds to the analyzed transcript.
(D)The linkage disequilibrium triangle and recombination inten-
sity profile of the population recombination rate (r/kb estimated
by InfRec), where, black lines connect SNPs distributed according
to sequence position (upper part) with their position in the LD
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transcript. Arrow on the top indicates transcription direction.
(TIF)
Figure S21 Relation between the linkage disequilibrium
between the R site and all tested SNPs (r
2 coefficient),
and the corresponding Minor Allele Frequency (MAF).
Green dash are for the SNPs above the rSNP, red slash are for
below and blue back-slash are for parallel SNPs. The four different
rSNP frequencies tested are shown.
(TIF)
Figure S22 Folded and unfolded allelic frequency spec-
tra from the different r frequencies sets of simulations.
Both spectra are from four subsets of 2000 simulations where a
rSNP of frequency 0.15 (black), 0.35 (red), 0.5 (blue) and 0.85
(green), could be assigned. The subsets are 2000, 1954, 1681 and
897 for 0.15, 0.35, 0.5 and 0.85, respectively.
(TIF)
Table S1 Lowest and mean p-values, expressed in
log(1/p), of the significant results of the three tests
performed on three sets of simulations, the ‘‘no-
recombination’’ set, the ‘‘recombination with phase
known’’ and the ‘‘recombination with re-phased data’’.
(DOCX)
Table S2 Distribution of segregating sites across gene-
alogical trees preselected to carry r alleles above certain
frequency threshold and its effect on r
2, derived allele
frequency (DAF) and power of the tests in each site
position category.
(DOCX)
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